Robotic capsule to deliver insulin?
Researchers at the Massachusetts Institute of Technology (MIT) have developed a new drug capsule with a robotic cap for improved drug delivery. Because large-protein drugs
Researchers at the Massachusetts Institute of Technology (MIT) have developed a new drug capsule with a robotic cap for improved drug delivery. Because large-protein drugs
Use of an older class of Type 2 diabetes drugs called glitazones (also known as thiazolidinediones or TZDs) is linked to a 22% reduced risk
The National Institute for Health and Care Research (NIHR) has announced a £26 million investment in an NIHR Leicester Biomedical Research Centre (BRC) – a
Eli Lilly plans to introduce a personalized diabetes management platform that integrates with technologies, including Dexcom’s continuous glucose monitoring (CGM) systems. The platform, branded Tempo,
A team of University of British Columbia (UBC) researchers has discovered that insulin from the oral insulin tablets they are developing is absorbed by rats
People from ethnic minority and marginalised community groups are being offered advice on health issues that disproportionately affect them. The Bristol Community Health Day on
The US Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide), Eli Lilly and Company’s new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)
Diabeloop has developed an algorithm that is hosted on a dedicated handset and serves as a bridge between continuous glucose monitors and insulin pumps. Every
Bariatric surgery has become more common as global rates of obesity have increased, but it may also raise the risk of developing epilepsy, according to
According to a study published in Diabetes Technology & Therapeutics, while closed-loop insulin delivery systems can increase glucose time in range and reduce hypoglycemia episodes